LEXINGTON, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the ...
LEXINGTON, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the execution ...
(RTTNews) - T2 Biosystems, Inc. (TTOO) said it plans to commercialize the T2Lyme Panel in the third quarter of 2024 as a laboratory developed test without the need to be run on the T2Dx Instrument ...
LEXINGTON, Mass., Feb. 15, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the ...
July 7 (Reuters) - T2 Biosystems Inc : * T2 Biosystems Inc says for Q2 ended June 30, 2016, company closed six commitments, four domestically and two in international markets Sign up here. * Currently ...
LEXINGTON, Mass. and SAN DIEGO, Sept. 06, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, ...
LEXINGTON, Mass., November 3, 2015 - T2 Biosystems, Inc. (NASDAQ: TTOO), a company developing innovative diagnostic products to improve patient health, today announced the appointment of veteran ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback